Department Of Pulmonary
Investigator
Emily DiMango, MD
Email
ead3@cumc.columbia.edu
Dr. DiMango is the Director of the Columbia University Gunnar Esiason Adult Cystic Fibrosis (CF) Program and the Asthma Research Program. The adult CF program cares for nearly 300 people with CF, with support from a dedicated multi-disciplinary team. She is co-Director of the Cystic Fibrosis Foundation Therapeutics Development Network at Columbia. She currently serves as Principal Investigator for numerous research projects in the areas of cystic fibrosis and asthma. Dr. DiMango currently serves as the national Chair of the Cystic Fibrosis Foundation (CFF) Therapeutics Development Network Program Protocol Review Committee.

Clinical Studies Managed By This Investigator:
Condition Study Title
Cystic Fibrosis [ CLOSED ] A study for patients with cystic fibrosis using study drug ataluren (PTC124)
Cystic Fibrosis [ CLOSED ] A study for subjects with non-cystic fibrosis bronchiectasis (NCFB) using study drug Pulmaquin to manage chronic lung infections
Cystic Fibrosis [ CLOSED ] A study for patients with Cystic Fibrosis using oral study drug CTX-4430
Cystic Fibrosis [ CLOSED ] A study for patients with Cystic Fibrosis using study drug VX-661
Lung Disease [ CLOSED ] Losartan Effects on Emphysema Progression (LEEP)
Asthma [ CLOSED ] Precise: Precision Interventions for Severe Asthma